Glenn Silver: Ledger

Stories naming Glenn Silver. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
	Finn Partners	Brandon Capital portfolio (Tue 10 Jan 2023), Brandon Capital portfolio (Wed 16 Mar 2022), Brandon Capital portfolio (Tue 28 Sep 2021), Brandon Capital portfolio (Tue 15 Jun 2021)

Funding announcement

First Participants Dosed in Phase 2a Study of Pan-Antiviral Nasal Spray

ENA Respiratory has begun a Phase 2a influenza-challenge trial in the UK of its INNA-051 antiviral nasal spray; the article also recalls its Series A backing by Brandon Capital, Minderoo Foundation and Uniseed.

Brandon Capital portfolio Wed 16 Mar 2022 Brandon Capital Partners ENA Respiratory Finn Partners Minderoo Foundation Uniseed Dr Christophe Demaison Glenn Silver

Glenn Silver

Roles

Coverage

First Participants Dosed in Phase 2a Study of Pan-Antiviral Nasal Spray

First-in-Class, Broad-Spectrum Nasal Spray to Prevent COVID-19 and Other Common Respiratory Illnesses Set to Begin Phase 2 Trials